{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:30Z","timestamp":1786979850942,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"DOI":"10.1007\/s00247-025-06476-z","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:41:14Z","timestamp":1764924074000},"page":"78-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in FDG PET imaging for staging and prognostic assessment in pediatric lymphoma: a systematic review"],"prefix":"10.1007","volume":"56","author":[{"given":"Fatemeh M.","family":"Ghazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyedAhmad","family":"SeyedAlinaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"6476_CR1","first-page":"100","volume":"20","author":"MR Hingorjo","year":"2008","unstructured":"Hingorjo MR, Syed S (2008) Presentation, staging and diagnosis of lymphoma: a clinical perspective. J Ayub Med Coll Abbottabad 20:100\u2013103","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"6476_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","volume":"37","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Kotb M, Hafez M, Sidhom I, Zamzam M, Zaky I, Abdel-Dayem H (2010) Role of PET\/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging 37:319\u2013329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6476_CR3","first-page":"35","volume":"1995","author":"C Percy","year":"1975","unstructured":"Percy C, Smith M, Linet M, Gloeckler Ries L, Friedman D (1975) Lymphomas and reticuloendothelial neoplasms US SEER 1995:35\u201350","journal-title":"Lymphomas and reticuloendothelial neoplasms US SEER"},{"key":"6476_CR4","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917","journal-title":"Int J Cancer"},{"key":"6476_CR5","first-page":"260","volume":"54","author":"BD Cheson","year":"2004","unstructured":"Cheson BD (2004) What is new in lymphoma? CA Cancer J Clin 54:260\u2013272","journal-title":"CA Cancer J Clin"},{"key":"6476_CR6","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019\u20135032","journal-title":"Blood"},{"key":"6476_CR7","doi-asserted-by":"crossref","unstructured":"Ansell SM (2015) Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 90:1574\u20131583","DOI":"10.1016\/j.mayocp.2015.07.005"},{"key":"6476_CR8","first-page":"896","volume":"94","author":"HL Gaddey","year":"2016","unstructured":"Gaddey HL, Riegel AM (2016) Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician 94:896\u2013903","journal-title":"Am Fam Physician"},{"key":"6476_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-hodgkin lymphoma. Lancet 390:298\u2013310","journal-title":"Lancet"},{"key":"6476_CR10","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133067","journal-title":"J Clin Oncol"},{"key":"6476_CR11","first-page":"368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55:368\u2013376","journal-title":"CA Cancer J Clin"},{"key":"6476_CR12","doi-asserted-by":"crossref","unstructured":"Guja KE, Nadel H, Iagaru A (2023) Overview and recent advances in 18F-FDG PET\/CT for evaluation of pediatric lymphoma. Semin Nucl Med 53: 400\u2013412","DOI":"10.1053\/j.semnuclmed.2022.10.001"},{"key":"6476_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","volume":"380","author":"W Townsend","year":"2012","unstructured":"Townsend W, Linch D (2012) Hodgkin\u2019s lymphoma in adults. Lancet 380:836\u2013847","journal-title":"Lancet"},{"key":"6476_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.6004\/jnccn.2024.0051","volume":"22","author":"B Shah","year":"2024","unstructured":"Shah B, Mattison RJ, Abboud R, Abdelmessieh P, Aldoss I, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J (2024) Acute lymphoblastic leukemia, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22:563\u2013576","journal-title":"J Natl Compr Canc Netw"},{"key":"6476_CR15","doi-asserted-by":"publisher","unstructured":"Van Heertum RL, Scarimbolo R, Wolodzko JG, Klencke B, Messmann R, Tunc F, Sokol L, Agarwal R, Strafaci JA, O\u2019Neal M (2017) Lugano 2014 criteria for assessing FDG-PET\/CT in lymphoma: an operational approach for clinical trials. Drug Des Dev Ther. https:\/\/doi.org\/10.2147\/DDDT.S136988","DOI":"10.2147\/DDDT.S136988"},{"key":"6476_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00247-016-3601-3","volume":"46","author":"MR Ponisio","year":"2016","unstructured":"Ponisio MR, McConathy J, Laforest R, Khanna G (2016) Evaluation of diagnostic performance of whole-body simultaneous PET\/MRI in pediatric lymphoma. Pediatr Radiol 46:1258\u20131268","journal-title":"Pediatr Radiol"},{"key":"6476_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1095-0397(00)00073-X","volume":"3","author":"M Martinelli","year":"2000","unstructured":"Martinelli M, Townsend D, Meltzer C, Villemagne V (2000) Survey of results of whole body imaging using the PET\/CT at the University of Pittsburgh Medical Center PET facility. Clin Positron Imaging 3:161\u2013161","journal-title":"Clin Positron Imaging"},{"key":"6476_CR18","first-page":"72S","volume":"45","author":"H Sch\u00f6der","year":"2004","unstructured":"Sch\u00f6der H, Larson SM, Yeung HW (2004) PET\/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med Technol 45:72S-81S","journal-title":"J Nucl Med Technol"},{"key":"6476_CR19","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1007\/s00330-016-4332-4","volume":"26","author":"M Aghighi","year":"2016","unstructured":"Aghighi M, Pisani LJ, Sun Z, Klenk C, Madnawat H, Fineman SL, Advani R, Von Eyben R, Owen D, Quon A, Moseley M, Daldrup-Link HE (2016) Speeding up PET\/MR for cancer staging of children and young adults. Eur Radiol 26:4239\u20134248","journal-title":"Eur Radiol"},{"key":"6476_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2014.00054","volume":"1","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eug\u00e8ne T, Couec ML, Strullu M, Frampas E, Campion L, Kraeber-Bod\u00e9r\u00e9 F, Bodet-Milin C (2014) Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med 1:1\u20137","journal-title":"Front Med"},{"key":"6476_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.116.176511","volume":"58","author":"S Bakhshi","year":"2017","unstructured":"Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Malhotra A, Dhawan D, Vishnubhatla S (2017) Posttreatment PET\/CT rather than interim PET\/CT using deauville criteria predicts outcome in pediatric hodgkin lymphoma: a prospective study comparing PET\/CT with conventional imaging. J Nucl Med 58:577\u2013583","journal-title":"J Nucl Med"},{"key":"6476_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10334-018-0726-4","volume":"32","author":"D Baranska","year":"2019","unstructured":"Baranska D, Matera K, Podgorski M, Gorska-Chrzastek M, Krajewska K, Trelinska J, Grzelak P (2019) Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET\/CT. Magn Reson Mater Phys Biol Med 32:381\u2013390","journal-title":"Magn Reson Mater Phys Biol Med"},{"key":"6476_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41824-024-00200-0","volume":"8","author":"N Bashank","year":"2024","unstructured":"Bashank N, Sharef S, Mohran TZ, Khalil M (2024) 18F-FDG PET\/CT versus bone marrow biopsy in detecting bone marrow infiltration in initial staging of pediatric lymphoma. EJNMMI rep 8:1\u201312","journal-title":"EJNMMI rep"},{"key":"6476_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12253-013-9676-3","volume":"20","author":"E B\u00e1rdi","year":"2014","unstructured":"B\u00e1rdi E, Cs\u00f3ka M, Garai I, Szegedi I, M\u00fcller J, Gy\u00f6rke T, Kaj\u00e1ry K, Nemes K, Kiss C, Kov\u00e1cs G (2014) Value of FDG-PET\/CT examinations in different cancers of children, focusing on lymphomas. Pathol Oncol Res 20:139\u2013143","journal-title":"Pathol Oncol Res"},{"key":"6476_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/bjh.13219","volume":"168","author":"D Bhojwani","year":"2015","unstructured":"Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, Inaba H, Davidoff AM, Gold R, Shulkin BL, Sandlund JT (2015) The role of FDG-PET\/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 168:845\u2013853","journal-title":"Br J Haematol"},{"key":"6476_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4274\/mirt.galenos.2020.64436","volume":"30","author":"N B\u0131\u00e7ak\u00e7\u0131","year":"2021","unstructured":"B\u0131\u00e7ak\u00e7\u0131 N, Elli M (2021) 18fluorine-fluorodeoxyglucose PET\/CT imaging in childhood malignancies. Mol Imaging Radionucl Ther 30:18\u201327","journal-title":"Mol Imaging Radionucl Ther"},{"key":"6476_CR27","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2967\/jnumed.118.222299","volume":"60","author":"JJ Cerci","year":"2019","unstructured":"Cerci JJ, Etchebehere EC, Nadel H, Brink A, Bal CS, Rangarajan V, Pfluger T, Kagna O, Alonso O, Begum FK, Mir KB, Magboo VP, Menezes LJ, Paez D, Pascual TN (2019) Is true whole-body 18F-FDG PET\/CT required in pediatric lymphoma? An IAEA multicenter prospective study. J Nucl Med 60:1087\u20131093","journal-title":"J Nucl Med"},{"key":"6476_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.17219\/acem\/68990","volume":"27","author":"R Chaber","year":"2018","unstructured":"Chaber R, Lasecki M, Kwasnicka J, Lach K, Podgajny Z, Olchowy C, Zaleska-Dorobisz U (2018) Hounsfield units from unenhanced 18F-FDG-PET\/CT are useful in evaluating supradiaphragmatic lymph nodes in children and adolescents with classical Hodgkin\u2019s lymphoma. Adv Clin Exp Med 27:795\u2013805","journal-title":"Adv Clin Exp Med"},{"key":"6476_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43055-022-00899-6","volume":"53","author":"HY Elhamady","year":"2022","unstructured":"Elhamady HY, Mostafa HM, Elsayed HF, Abo-ElAzm OM, Hussein MH (2022) Deauville score versus ratio Deauville score in the interpretation of interim 18F-FDG PET-CT and in prediction of outcome in children with FDG-avid extra-nodal lymphomas. Egypt J Radiol Nucl Med 53:1\u201313","journal-title":"Egypt J Radiol Nucl Med"},{"key":"6476_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-3-71","volume":"3","author":"C Furth","year":"2013","unstructured":"Furth C, Steffen IG, Erdrich AS, Hundsdoerfer P, Ruf J, Henze G, Sch\u00f6nberger S, Amthauer H, Hautzel H (2013) Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients. EJNMMI Res 3:1\u201311","journal-title":"EJNMMI Res"},{"key":"6476_CR31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.2967\/jnumed.117.205633","volume":"59","author":"TW Georgi","year":"2018","unstructured":"Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fern\u00e1ndez-Teijeiro A, Cepelova M, Foss\u00e5 A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, K\u00f6rholz D, Sabri O, Mauz-K\u00f6rholz C (2018) 18F-FDG PET response of skeletal (Bone Marrow and Bone) involvement after induction chemotherapy in pediatric hodgkin lymphoma: are specific response criteria required? J Nucl Med 59:1524\u20131530","journal-title":"J Nucl Med"},{"key":"6476_CR32","first-page":"1","volume":"13","author":"C Giraudo","year":"2023","unstructured":"Giraudo C, Carraro E, Cavallaro E, Zuliani M, Spampinato Gotsyak L, Massano D, Modugno A, Mussolin L, Biffi A, Cecchin D, Pillon M, Zucchetta P (2023) [18F]FDG PET-MR in the evaluation and follow-up of incidental bone ischemic lesions in a mono-center cohort of pediatric patients affected by Hodgkin\u2019s lymphoma. Diagn 13:1\u201310","journal-title":"Diagn"},{"key":"6476_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00247-012-2570-4","volume":"43","author":"FW Hirsch","year":"2013","unstructured":"Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013) PET\/MR in children. Initial clinical experience in paediatric oncology using an integrated PET\/MR scanner. Pediatr Radiol 43:860\u2013875","journal-title":"Pediatr Radiol"},{"key":"6476_CR34","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1007\/s00330-023-09840-5","volume":"33","author":"K Jannusch","year":"2023","unstructured":"Jannusch K, Morawitz J, Schweiger B, Weiss D, Schimm\u00f6ller L, Minko P, Herrmann K, Fendler WP, Quick HH, Antoch G, Umutlu L, Kirchner J, Bruckmann NM (2023) [18F]FDG PET\/MRI in children suffering from lymphoma: does MRI contrast media make a difference? Eur Radiol 33:8366\u20138375","journal-title":"Eur Radiol"},{"key":"6476_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149072","volume":"11","author":"R Kluge","year":"2016","unstructured":"Kluge R, Chavdarova L, Hoffmann M, Kobe C, Malkowski B, Montravers F, Kurch L, Georgi T, Dietlein M, Wallace WH, Karlen J, Fern\u00e1ndez-Teijeiro A, Cepelova M, Wilson L, Bergstraesser E, Sabri O, Mauz-K\u00f6rholz C, K\u00f6rholz D, Hasenclever D (2016) Inter-reader reliability of early FDG-PET\/CT response assessment using the Deauville scale after 2 cycles of intensive chemotherapy (OEPA) in Hodgkin\u2019s lymphoma. PLoS One 11:1\u201314","journal-title":"PLoS One"},{"key":"6476_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-021-00804-8","volume":"11","author":"L Kurch","year":"2021","unstructured":"Kurch L, Kluge R, Sabri O, Fischer L, Wendt S, Graf Einsiedel H, Starke S, K\u00fchl JS, Christiansen H, Hirsch FW, Sorge I, Roth C (2021) Whole-body [18F]-FDG-PET\/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation. EJNMMI Res 11:1\u201315","journal-title":"EJNMMI Res"},{"key":"6476_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00330-018-5445-8","volume":"29","author":"A Latifoltojar","year":"2019","unstructured":"Latifoltojar A, Punwani S, Lopes A, Humphries PD, Klusmann M, Menezes LJ, Daw S, Shankar A, Neriman D, Fitzke H, Clifton-Hadley L, Smith P, Taylor SA (2019) Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin\u2019s lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT. Eur Radiol 29:202\u2013212","journal-title":"Eur Radiol"},{"key":"6476_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00330-023-10015-5","volume":"34","author":"W Morakote","year":"2024","unstructured":"Morakote W, Baratto L, Ramasamy SK, Adams LC, Liang T, Sarrami AH, Daldrup-Link HE (2024) Comparison of diffusion-weighted MRI and [18F]FDG PET\/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma. Eur Radiol 34:643\u2013653","journal-title":"Eur Radiol"},{"key":"6476_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/RLU.0b013e318238f72b","volume":"37","author":"K Nakatani","year":"2012","unstructured":"Nakatani K, Nakamoto Y, Watanabe K, Saga T, Higashi T, Togashi K (2012) Roles and limitations of FDG PET in pediatric non-Hodgkin lymphoma. Clin Nucl Med 37:656\u2013662","journal-title":"Clin Nucl Med"},{"key":"6476_CR40","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.12669\/pjms.39.6.7721","volume":"39","author":"S Naveed","year":"2023","unstructured":"Naveed S, Faheem H, Shazlee K, Ashraf MS (2023) Diagnostic accuracy of18F-FDG PET-CT imaging in determining the bone marrow involvement (BMI) in pediatric Hodgkin\u2019s lymphoma (HL). Pak J Med Sci 39:1830\u20131834","journal-title":"Pak J Med Sci"},{"key":"6476_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/08880018.2012.684198","volume":"29","author":"N Rathore","year":"2012","unstructured":"Rathore N, Eissa HM, Margolin JF, Liu H, Wu MF, Horton T, Kamdar K, Dreyer Z, Steuber P, Rabin KR, Redell M, Allen CE, McClain KL, Guillerman RP, Bollard CM (2012) Pediatric Hodgkin lymphoma: are we over-scanning our patients. Pediatr Hematol Oncol 29:415\u2013423","journal-title":"Pediatr Hematol Oncol"},{"key":"6476_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10245979","volume":"10","author":"JD Reed","year":"2021","unstructured":"Reed JD, Masenge A, Buchner A, Omar F, Reynders D, Vorster M, van de Wiele C, Sathekge M (2021) The utility of metabolic parameters on baseline F-18 FDG PET\/CT in predicting treatment response and survival in paediatric and adolescent Hodgkin lymphoma. J Clin Med 10:1\u201315","journal-title":"J Clin Med"},{"key":"6476_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4432-4","volume":"18","author":"JMM Rogasch","year":"2018","unstructured":"Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C (2018) Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin\u2019s lymphoma. BMC Cancer 18:1\u20139","journal-title":"BMC Cancer"},{"key":"6476_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2214\/AJR.10.6074","volume":"196","author":"MBK Sammer","year":"2011","unstructured":"Sammer MBK, Shulkin BL, Alessio A, Parisi MT (2011) Role of limited whole-body PET\/CT in pediatric lymphoma. AJR Am J Roentgenol 196:1047\u20131055","journal-title":"AJR Am J Roentgenol"},{"key":"6476_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1055\/s-0041-1730240","volume":"42","author":"A Seshachalam","year":"2021","unstructured":"Seshachalam A, Karpurmath SV, Rathnam K, Srinivasan A, Scott J, G RS, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Golamari KR, Danthala M, Malipatil B, Rangarajan B, Udupa KS, Nandennavar M, Niraimathi K (2021) Role of interim PET scan after 2 cycles of ABVD in pediatric Hodgkin lymphoma: retrospective multicenter study from south India. Indian J Med Paediatr Oncol 42:415\u2013425","journal-title":"Indian J Med Paediatr Oncol"},{"key":"6476_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/0972-3919.112717","volume":"27","author":"R Seth","year":"2012","unstructured":"Seth R, Puri K, Singh P, Selvam P, Kumar R (2012) The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma. Indian J Nucl Med 27:141\u2013144","journal-title":"Indian J Nucl Med"},{"key":"6476_CR47","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s00330-020-07182-0","volume":"31","author":"S Spijkers","year":"2021","unstructured":"Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enr\u00edquez G, S\u00e1bado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MLC, de Keizer B, Nievelstein RAJ (2021) Whole-body MRI versus an FDG-PET\/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study. Eur Radiol 31:1494\u20131504","journal-title":"Eur Radiol"},{"key":"6476_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.24953\/turkjped.2020.02.003","volume":"62","author":"\u00d6 Tezol","year":"2020","unstructured":"Tezol \u00d6, Sa\u011fcan F, \u00d6zcan PP, \u00c7\u0131tak E\u00c7 (2020) Bone marrow involvement in pediatric malignancies: a comparison study of positron emission tomography-computed tomography and bone marrow biopsy. Turk J Pediatr 62:182\u2013190","journal-title":"Turk J Pediatr"},{"key":"6476_CR49","first-page":"524","volume":"62","author":"MV Verhagen","year":"2021","unstructured":"Verhagen MV, Menezes LJ, Neriman D, Watson TA, Punwani S, Taylor SA, Shankar A, Daw S, Humphries PD (2021) 18F-FDG PET\/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET\/CT as reference standard. J Nucl Med Technol 62:524\u2013530","journal-title":"J Nucl Med Technol"},{"key":"6476_CR50","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.926544","volume":"26","author":"M Gallach","year":"2020","unstructured":"Gallach M, Lette MM, Abdel-Wahab M, Giammarile F, Pellet O, Paez D (2020) Addressing global inequities in positron emission tomography-computed tomography (PET-CT) for cancer management: a statistical model to guide strategic planning. Med Sci Monit 26:e926544\u2013926541\u2013e926544\u2013926548","journal-title":"Med Sci Monit"},{"key":"6476_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-019-0577-7","volume":"9","author":"J Blautzik","year":"2019","unstructured":"Blautzik J, Grelich L, Schramm N, Henkel R, Bartenstein P, Pfluger T (2019) What and how should we measure in paediatric oncology FDG-PET\/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours. EJNMMI Res 9:1\u20139","journal-title":"EJNMMI Res"},{"key":"6476_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0229859","volume":"15","author":"R Chaber","year":"2020","unstructured":"Chaber R, \u0141asecki M, Kuczy\u0144ski K, Cebryk R, Kwa\u015bnicka J, Olchowy C, \u0141ach K, Pogodajny Z, Koptiuk O, Olchowy A, Popecki P, Zaleska-Dorobisz U (2020) Hounsfield units and fractal dimension (test HUFRA) for determining PET positive\/negative lymph nodes in pediatric Hodgkin\u2019s lymphoma patients. PLoS ONE 15:1\u201314","journal-title":"PLoS ONE"},{"key":"6476_CR53","first-page":"148","volume":"52","author":"C Furth","year":"2013","unstructured":"Furth C, Erdrich AS, Steffen IG, Ruf J, Stiebler M, Kahraman D, Kobe C, Sch\u00f6nberger S, Grandt R, Hundsdoerfer P, Hauptmann K, Amthauer H, Hautzel H (2013) Interim PET response criteria in paediatric non-Hodgkin\u2019s lymphoma: results from a retrospective multicenter reading. Nuklearmedizin 52:148\u2013156","journal-title":"Nuklearmedizin"},{"key":"6476_CR54","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00247-019-04463-9","volume":"49","author":"A Latifoltojar","year":"2019","unstructured":"Latifoltojar A, Humphries PD, Menezes LJ, Haroon A, Daw S, Shankar A, Punwani S (2019) Whole-body magnetic resonance imaging in paediatric Hodgkin lymphoma \u2014 evaluation of quantitative magnetic resonance metrics for nodal staging. Pediatr Radiol 49:1285\u20131298","journal-title":"Pediatr Radiol"},{"key":"6476_CR55","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","volume":"32","author":"DL Friedman","year":"2014","unstructured":"Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the children\u2019s oncology group study AHOD0031. J Clin Oncol 32:3651\u20133658","journal-title":"J Clin Oncol"},{"key":"6476_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00330-024-10957-4","volume":"35","author":"C Giraudo","year":"2025","unstructured":"Giraudo C, Cavallin C, Pillon M, Carraro E, Fichera G, Cecchin D, Zucchetta P (2025) Automatic assessment of body composition in children with lymphoma: results of a [18F]FDG-PET\/MR study. Eur Radiol 35:341\u2013350","journal-title":"Eur Radiol"},{"key":"6476_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.semnuclmed.2017.01.001","volume":"47","author":"R Kluge","year":"2017","unstructured":"Kluge R, Kurch L, Georgi T, Metzger M (2017) Current role of FDG-PET in pediatric Hodgkin\u2019s lymphoma. Semin Nucl Med 47:242\u2013257","journal-title":"Semin Nucl Med"},{"key":"6476_CR58","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jmri.25711","volume":"46","author":"EC Ehman","year":"2017","unstructured":"Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA (2017) PET\/MRI: where might it replace PET\/CT? J Magn Reson Imaging 46:1247\u20131262","journal-title":"J Magn Reson Imaging"},{"key":"6476_CR59","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2214\/AJR.14.13181","volume":"204","author":"L Heacock","year":"2015","unstructured":"Heacock L, Weissbrot J, Raad R, Campbell N, Friedman KP, Ponzo F, Chandarana H (2015) PET\/MRI for the evaluation of patients with lymphoma: initial observations. AJR Am J Roentgenol 204:842\u2013848","journal-title":"AJR Am J Roentgenol"},{"key":"6476_CR60","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","volume":"52","author":"G Delso","year":"2011","unstructured":"Delso G, F\u00fcrst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, Schwaiger M, Ziegler SI (2011) Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner. J Nucl Med 52:1914\u20131922","journal-title":"J Nucl Med"},{"key":"6476_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2967\/jnmt.119.236109","volume":"48","author":"I Sarikaya","year":"2020","unstructured":"Sarikaya I, Sarikaya A (2020) Assessing PET parameters in oncologic 18F-FDG studies. J Nucl Med Technol 48:278\u2013282","journal-title":"J Nucl Med Technol"},{"key":"6476_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/jcp.19.4.389","volume":"19","author":"R Hume","year":"1966","unstructured":"Hume R (1966) Prediction of lean body mass from height and weight. J Clin Pathol 19:389\u2013391","journal-title":"J Clin Pathol"},{"key":"6476_CR63","first-page":"1","volume":"60","author":"J Devriese","year":"2015","unstructured":"Devriese J, Beels L, Maes A, de Van Wiele C, Gheysens O, Pottel H (2015) Review of clinically accessible methods to determine lean body mass for normalization of standardized uptake values. Q J Nucl Med Mol Imaging 60:1\u201311","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"6476_CR64","unstructured":"Sugawara Y, Shulkin B, Zasadny K, Wahl R (2000) Standardized uptake values of FDG in pediatric patients: variations with patient characteristics and methods for corrections. J Nucl Med 41:96P\u201396P"},{"key":"6476_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00259-001-0662-8","volume":"29","author":"H Yeung","year":"2002","unstructured":"Yeung H, Sanches A, Squire O, Macapinlac H, Larson S, Erdi Y (2002) Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter. Eur J Nucl Med Mol Imaging 29:61\u201366","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6476_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ejrad.2010.11.020","volume":"81","author":"W Lm","year":"2012","unstructured":"Lm W (2012) F-FDG PET, combined FDG-PET\/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis. Eur J Radiol 81:303\u2013311","journal-title":"Eur J Radiol"},{"key":"6476_CR67","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdt533","volume":"25","author":"H Adams","year":"2014","unstructured":"Adams H, Kwee T, De Keizer B, Fijnheer R, de Klerk J, Littooij A, Nievelstein R (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25:921\u2013927","journal-title":"Ann Oncol"},{"key":"6476_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12149-012-0665-5","volume":"27","author":"K Agrawal","year":"2013","unstructured":"Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK (2013) Role of F-18 FDG PET\/CT in assessing bone marrow involvement in pediatric Hodgkin\u2019s lymphoma. Ann Nucl Med 27:146\u2013151","journal-title":"Ann Nucl Med"},{"key":"6476_CR69","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2010","unstructured":"Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA (2010) 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol 75:e68\u2013e73","journal-title":"Eur J Radiol"},{"key":"6476_CR70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MNM.0b013e328334fc14","volume":"31","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Sidhom I, Zamzam M, Zaky I, Hafez M, Abdel-Dayem HM (2010) False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt\u2019s lymphoma. Nucl Med Commun 31:232\u2013238","journal-title":"Nucl Med Commun"},{"key":"6476_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ejh.12284","volume":"94","author":"E Carrillo\u2010Cruz","year":"2015","unstructured":"Carrillo\u2010Cruz E, Mar\u00edn\u2010Oyaga VA, Rodr\u00edguez MS, Borrego\u2010Dorado I, de la Cruz Vicente F, Quiroga Cantero E, P\u00e9rez MM, Capote FJ, Ram\u00edrez S\u00e1nchez MJ, Espigado Tocino I (2015) Role of 18F\u2010FDG\u2010PET\/CT in the management of Burkitt lymphoma. Eur J Haematol 94:23\u201330","journal-title":"Eur J Haematol"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-025-06476-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-025-06476-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-025-06476-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T13:02:57Z","timestamp":1769259777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-025-06476-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6476"],"URL":"https:\/\/doi.org\/10.1007\/s00247-025-06476-z","relation":{},"ISSN":["1432-1998"],"issn-type":[{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent is not applicable for this type of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}